Trial Outcomes & Findings for mHealth for Breast Cancer Survivors With Insomnia (NCT NCT05233800)

NCT ID: NCT05233800

Last Updated: 2025-01-24

Results Overview

Data will be collected on the Insomnia Severity Index (ISI) total score pre- and post-intervention as our primary outcome. The ISI is a seven-item questionnaire with response categories from 0-4 (total score 0-28) asking about sleep patterns and specifically characterizing insomnia over the two weeks prior. The ISI defines 'no clinically significant' insomnia as a score of 0-7, 'sub-threshold' insomnia as a score of 8-14, 'moderate severity clinical' insomnia' a scores of 15-21, and 'severe clinical' insomnia as a score of 22-28. Clinically relevant target for success is to achieve sub-threshold or better scores (≤14) among \>80% of the intervention participants

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

76 participants

Primary outcome timeframe

6 weeks

Results posted on

2025-01-24

Participant Flow

Participant milestones

Participant milestones
Measure
Voice-Activated Smart Speaker Program
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
Overall Study
STARTED
38
38
Overall Study
COMPLETED
35
35
Overall Study
NOT COMPLETED
3
3

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

mHealth for Breast Cancer Survivors With Insomnia

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Voice-Activated Smart Speaker Program
n=38 Participants
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
n=38 Participants
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
Total
n=76 Participants
Total of all reporting groups
Age, Continuous
62.6 years
STANDARD_DEVIATION 9.8 • n=5 Participants
59.8 years
STANDARD_DEVIATION 8.7 • n=7 Participants
61.2 years
STANDARD_DEVIATION 9.3 • n=5 Participants
Sex: Female, Male
Female
38 Participants
n=5 Participants
38 Participants
n=7 Participants
76 Participants
n=5 Participants
Sex: Female, Male
Male
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Hispanic or Latino
2 Participants
n=5 Participants
0 Participants
n=7 Participants
2 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
36 Participants
n=5 Participants
38 Participants
n=7 Participants
74 Participants
n=5 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Asian
0 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
Race (NIH/OMB)
Black or African American
7 Participants
n=5 Participants
9 Participants
n=7 Participants
16 Participants
n=5 Participants
Race (NIH/OMB)
White
28 Participants
n=5 Participants
25 Participants
n=7 Participants
53 Participants
n=5 Participants
Race (NIH/OMB)
More than one race
2 Participants
n=5 Participants
1 Participants
n=7 Participants
3 Participants
n=5 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants
n=5 Participants
1 Participants
n=7 Participants
2 Participants
n=5 Participants
Region of Enrollment
United States
38 participants
n=5 Participants
38 participants
n=7 Participants
76 participants
n=5 Participants
Marital status
Single
6 Participants
n=5 Participants
7 Participants
n=7 Participants
13 Participants
n=5 Participants
Marital status
Married or partnered
25 Participants
n=5 Participants
24 Participants
n=7 Participants
49 Participants
n=5 Participants
Marital status
Divorced or separated
5 Participants
n=5 Participants
5 Participants
n=7 Participants
10 Participants
n=5 Participants
Marital status
Widowed
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
Employment
Full Time
13 Participants
n=5 Participants
16 Participants
n=7 Participants
29 Participants
n=5 Participants
Employment
Part time
4 Participants
n=5 Participants
7 Participants
n=7 Participants
11 Participants
n=5 Participants
Employment
Retired
16 Participants
n=5 Participants
15 Participants
n=7 Participants
31 Participants
n=5 Participants
Employment
Unemployed
5 Participants
n=5 Participants
0 Participants
n=7 Participants
5 Participants
n=5 Participants
Education
High school/GED/Some college
6 Participants
n=5 Participants
4 Participants
n=7 Participants
10 Participants
n=5 Participants
Education
College Degree
14 Participants
n=5 Participants
16 Participants
n=7 Participants
30 Participants
n=5 Participants
Education
Graduate Degree
18 Participants
n=5 Participants
18 Participants
n=7 Participants
36 Participants
n=5 Participants
TNM Cancer Stage at diagnosis
Stage 0
0 Participants
n=5 Participants
2 Participants
n=7 Participants
2 Participants
n=5 Participants
TNM Cancer Stage at diagnosis
Stage 1
21 Participants
n=5 Participants
12 Participants
n=7 Participants
33 Participants
n=5 Participants
TNM Cancer Stage at diagnosis
Stage 2
12 Participants
n=5 Participants
17 Participants
n=7 Participants
29 Participants
n=5 Participants
TNM Cancer Stage at diagnosis
Stage 3
3 Participants
n=5 Participants
5 Participants
n=7 Participants
8 Participants
n=5 Participants
TNM Cancer Stage at diagnosis
Stage 4
2 Participants
n=5 Participants
2 Participants
n=7 Participants
4 Participants
n=5 Participants
BMI
25.9 kg/m2
n=5 Participants
25.6 kg/m2
n=7 Participants
25.8 kg/m2
n=5 Participants

PRIMARY outcome

Timeframe: 6 weeks

Population: Intent to treat

Data will be collected on the Insomnia Severity Index (ISI) total score pre- and post-intervention as our primary outcome. The ISI is a seven-item questionnaire with response categories from 0-4 (total score 0-28) asking about sleep patterns and specifically characterizing insomnia over the two weeks prior. The ISI defines 'no clinically significant' insomnia as a score of 0-7, 'sub-threshold' insomnia as a score of 8-14, 'moderate severity clinical' insomnia' a scores of 15-21, and 'severe clinical' insomnia as a score of 22-28. Clinically relevant target for success is to achieve sub-threshold or better scores (≤14) among \>80% of the intervention participants

Outcome measures

Outcome measures
Measure
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
n=35 Participants
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
Insomnia Symptoms
-8.4 units on a scale
Standard Deviation 4.7
-2.6 units on a scale
Standard Deviation 3.5

SECONDARY outcome

Timeframe: 6 weeks

Population: Intent to treat

Sleep efficiency is calculated by the total time sleeping over the total time in bed.

Outcome measures

Outcome measures
Measure
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
n=35 Participants
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
Six Week Change in Sleep Efficiency
0.09 proportion of time asleep/time in bed
Interval 0.07 to 0.11
0.05 proportion of time asleep/time in bed
Interval 0.03 to 0.07

SECONDARY outcome

Timeframe: 6 weeks

Population: Intent to treat

Amount of time awake during the night

Outcome measures

Outcome measures
Measure
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
n=35 Participants
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
Six Week Change in Wake After Sleep Onset
-18.6 minutes
Interval -23.9 to -13.36
-9.1 minutes
Interval -14.6 to -3.63

SECONDARY outcome

Timeframe: 6 weeks

Population: Intent to treat

Time to fall asleep

Outcome measures

Outcome measures
Measure
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
n=35 Participants
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
Six Week Change in Sleep Onset Latency
-13.79 minutes
Interval -18.2 to -9.33
-5.46 minutes
Interval -10.1 to -0.86

SECONDARY outcome

Timeframe: 6 weeks

Population: Intent to treat

Total time asleep

Outcome measures

Outcome measures
Measure
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
n=35 Participants
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
Six Week Change in Total Sleep Time
0.26 hours
Interval 0.06 to 0.45
0.27 hours
Interval 0.06 to 0.47

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 weeks

Population: intent to treat

A 10-item scale on general usability of technology. This provides a score of 0-100, with above 68 indicating better than average usability, where higher is better. This is a normalized score and not a percentage.

Outcome measures

Outcome measures
Measure
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
n=35 Participants
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
System Usability Scale
72.2 score on a scale
Standard Deviation 16.6
50.79 score on a scale
Standard Deviation 15.9

OTHER_PRE_SPECIFIED outcome

Timeframe: 6 weeks

Population: Intent to treat

5-item Likert scale from Very Poor (5) to Very Good (1).

Outcome measures

Outcome measures
Measure
Voice-Activated Smart Speaker Program
n=35 Participants
Faster Asleep Faster Asleep Smart Speaker Program: Participants will receive a smart speaker device with a pre-loaded Faster Asleep program. Participants will be asked to engage with the program daily, either using the voice-activated speakers or an accompanying smart-phone app. The study duration is six-weeks and is completed individually using fully automated interaction to deliver components of cognitive behavioral therapy for insomnia.
Website
n=35 Participants
Faster Asleep Website Faster Asleep Website: Controls will have access to a website with information about CBT-I and breast cancer survivorship and will be told to engage with the website as desired. The content will be drawn from the education script that is programmed into the phone app accompanying the smart speaker program.
End of Study Self-reported Sleep Quality
2.44 score on a scale
Standard Deviation 0.08
3.03 score on a scale
Standard Deviation 0.08

Adverse Events

Voice-Activated Smart Speaker Program

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Website

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Hannah Arem, Scientific Director, Implementation Science

MedStar Health Research Institute

Phone: 2028932430

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place